Increasing unusual option volume: MULN EQNR APLS WEAT CTIC

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Increasing unusual option volume: MULN EQNR APLS WEAT CTIC

CTI BioPharma (CTIC) PT Raised to $12 at Brookline Capital Markets Following FDA Approval

March 1, 2022 10:13 AM EST

Brookline Capital Markets analyst Leah Rush Cann raised the price target on CTI BioPharma (NASDAQ: CTIC) to $12.00 (from $7.20) while maintaining a Buy rating following FDA approval for Pacritinib (Vonjo) in Myelofibrosis.

The analyst commented, "The timing of this FDA-approval is as expected and the prescribing label, with no black box warning and an... More